Middle East Healthcare Company (SASE: 4009)
Health Care · Health Care Providers & Services · SA
SR27.66
-1.98% today · -51.5% 1Y
Middle East Healthcare Company (SASE: 4009) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $678.06M.
Over the last twelve months the share price has lost 51.5%, trading between 28.12 and 59.20.
Tweenvest scores Middle East Healthcare Company across four factors: quality 67/100, value 80/100, dividend 36/100. Its strongest factor is value.
4009 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $678.06M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- 1.81%
- Beta (5Y)
- -0.01
- 52-week high
- SR59.20
- 52-week low
- SR28.12
- Avg volume (3M)
- —
- Shares outstanding
- 92.04M
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Amal Holdings A.D. Ltd.TASE: AMAL | $714.78M | ₪15.64 | -1.64% |
| PT Metro Healthcare Indonesia TbkIDX: CARE | $702.39M | Rp378.00 | +1.61% |
| Shanghai Labway Clinical Laboratory Co., LtdSZSE: 301060 | $700.88M | CN¥11.78 | -2.00% |
| Bright Eye Hospital Group Co., Ltd.SZSE: 301239 | $696.30M | CN¥31.33 | -2.03% |
| Starling Oncology, Inc.NasdaqCM: STLN | $675.70M | $6.81 | +2.71% |
| Kovai Medical Center and Hospital LimitedBSE: 523323 | $664.77M | Rs5,879.70 | -2.03% |
| Nephrocare Health Services LimitedNSEI: NEPHROPLUS | $640.46M | Rs616.40 | -5.02% |
| SALUS, Ljubljana, d. d.LJSE: SALR | $639.61M | €69.50 | -1.42% |
Figures last refreshed Oct 11, 2026.